Evidence map›Paper›PMID 27272748›Full record

ArticleTobacco control2017

Cohort study of electronic cigarette use: effectiveness and safety at 24 months.

Lamberto Manzoli, Maria Elena Flacco, Margherita Ferrante, Carlo La Vecchia, Roberta Siliquini, Walter Ricciardi, Carolina Marzuillo, Paolo Villari, Maria Fiore, ISLESE Working Group

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Tobacco control, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01785537 (Multicentric 5-year Follow-up Study to Assess the Efficacy of E-cigarettes as a Tool for Smoking Cessation and to Compare the Risk of Smoking-related Diseases Among Electronic and Traditional Cigarette Smokers, and Smokers of Both.), which is not on this map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01785537 unknown statusnot on this map

Multicentric 5-year Follow-up Study to Assess the Efficacy of E-cigarettes as a Tool for Smoking Cessation and to Compare the Risk of Smoking-related Diseases Among Electronic and Traditional Cigarette Smokers, and Smokers of Both.

TypeobservationalSponsorUniversità degli Studi 'G. d'Annunzio' Chieti e PescaraRan2013 to 2019Enrolled1,050ConditionsCardiovascular Diseases, Chronic Obstructive Pulmonary Diseases, Cancer of the Lung, Cancer of the Bladder
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Vaping, Smoking and Lung Cancer Risk.Journal of oncology research and therapy · 2024
    Article
  13. Applying the Population Health Standard to the Regulation of Electronic Nicotine Delivery Systems.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Review
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Lamberto ManzoliDepartment of Medicine and Aging Sciences, University of Chieti, Chieti, Italy.
Maria Elena FlaccoDepartment of Medicine and Aging Sciences, University of Chieti, Chieti, Italy.
Margherita FerranteDepartment "G. F. Ingrassia"-Hygiene and Public Health, University of Catania, Catania, Italy.
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Roberta SiliquiniDepartment of Public Health Sciences, University of Turin, Turin, Italy.
Walter RicciardiItalian National Institute of Health, Rome, Italy.
Carolina MarzuilloDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Roma, Italy.
Paolo VillariDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Roma, Italy.
Maria FioreDepartment "G. F. Ingrassia"-Hygiene and Public Health, University of Catania, Catania, Italy.
ISLESE Working Group
Sapienza University of Rome · ITUniversity of Catania · ITAgenzia Sanitaria Regionale Abruzzo · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Chieti-Pescara · ITUniversity of Milan · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the safety and effectiveness of e-cigarettes, by comparing users of only e-cigarettes, smokers of only tobacco cigarettes and dual users.

designProspective cohort study. We update previous 12-month findings and report the results of the 24-month follow-up. DATA SOURCES: Direct contact and questionnaires by phone or via internet.

methodsAdults (30-75 years) were classified as: (1) tobacco smokers, if they smoked ≥1 tobacco cigarette/day, (2) e-cigarette users, if they inhaled ≥50 puffs/week of any type of e-cigarette and (3) dual users, if they smoked tobacco cigarettes and also used e-cigarettes. Carbon monoxide levels were tested in 50% of those declaring tobacco smoking abstinence. Hospital discharge data were used to validate possibly related serious adverse events in 46.0% of the sample.

main outcome measuresSustained abstinence from tobacco cigarettes and/or e-cigarettes after 24 months, the difference in the number of tobacco cigarettes smoked daily between baseline and 24 months, possibly related serious adverse events.

resultsData at 24 months were available for 229 e-cigarette users, 480 tobacco smokers and 223 dual users (overall response rate 68.8%). Of the e-cigarette users, 61.1% remained abstinent from tobacco (while 23.1% and 26.0% of tobacco-only smokers and dual users achieved tobacco abstinence). The rate (18.8%) of stopping use of either product (tobacco and/or e-cigarettes) was not higher for e-cigarette users compared with tobacco smokers or dual users. Self-rated health and adverse events were similar between all groups. Among those continuing to smoke, there were no differences in the proportion of participants reducing tobacco cigarette consumption by 50% or more, the average daily number of cigarettes and the average self-rated health by baseline group. Most dual users at baseline abandoned e-cigarettes and continued to smoke tobacco. Those who continued dual using or converted from tobacco smoking to dual use during follow-up experienced significant improvements in the 3 outcomes compared with those who continued or switched to only smoking tobacco (p<0.001).

conclusionsE-cigarette use alone might support tobacco quitters remaining abstinent from smoking. However, dual use did not improve the likelihood of quitting tobacco or e-cigarette use, but may be helpful to reduce tobacco consumption. Adverse event data were scarce and must be considered preliminary. TRIAL REGISTRATION NUMBER: NCT01785537.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsAdultAgedCohort StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesSmokingSmoking CessationSurveys and QuestionnairesCessationElectronic nicotine delivery devicesHarm Reduction

Identifiers

PMID27272748
PMCPMC5520273
OpenAlexW2410589274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.